Evolving Neoadjuvant, Adjuvant, and Concurrent Systemic Therapy Strategies in Head and Neck Squamous Carcinoma.
1/5 보강
The role of cytotoxic chemotherapy in the neoadjuvant setting has not been well established by older studies, except in the case of larynx preservation.
APA
Menon N (2026). Evolving Neoadjuvant, Adjuvant, and Concurrent Systemic Therapy Strategies in Head and Neck Squamous Carcinoma.. Otolaryngologic clinics of North America, 59(1), 127-146. https://doi.org/10.1016/j.otc.2025.08.022
MLA
Menon N. "Evolving Neoadjuvant, Adjuvant, and Concurrent Systemic Therapy Strategies in Head and Neck Squamous Carcinoma.." Otolaryngologic clinics of North America, vol. 59, no. 1, 2026, pp. 127-146.
PMID
41152067 ↗
Abstract 한글 요약
The role of cytotoxic chemotherapy in the neoadjuvant setting has not been well established by older studies, except in the case of larynx preservation. Novel neoadjuvant strategies are being explored, such as the incorporation of immune checkpoint inhibitors into the neoadjuvant/peri-operative setting, novel combinations of chemotherapy with ICI and/or metronomic therapy, and the use of neoadjuvant chemo-immunotherapy for response-adapted de-escalation of radiotherapy. IAP (inhibitor of apoptosis protein) antagonists are novel agents being investigated in HNSCC, but have not shown benefit in the phase III setting.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.